Funding Update
UFHCC + Extramural Opportunities
Extramural Opportunities
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
Limited Extramural
V Foundation
2019 V Foundation V Scholar Cancer Research Grant
Application: 3/15/19
Other Extramural
Cancer Research Institute
Lloyd J. Old STAR Program
LOI: 3/1/19
National Institute of Health
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)
Application: 2/26/19
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed)
Application: 2/27/19
NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed)
Application: 4/01/19
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/19
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/19
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Application: 9/28/19
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)
Application: 9/28/19
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
Application: 1/4/20
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
Application: 8/4/20
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Application: 1/8/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Application: 1/8/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
Application: 1/8/22
Biology of Bladder Cancer (R01 Clinical Trial Optional)
Application: 5/8/22
Biology of Bladder Cancer (R21 Clinical Trial Optional)
Application: 5/8/22
Department of Defense
Breast Cancer Research Program: Breakthrough Award Level 3
Application: 3/12/19
Breast Cancer Research Program: Breakthrough Award Level 4
Application: 3/12/19
Breast Cancer Research Program: Distinguished Investigator Award
Application: 3/12/19
Breast Cancer Research Program: Innovator Award
Application: 3/12/19
Breast Cancer Research Program: Breakthrough Award Levels 1 and 2
Application: 3/14/19
Breast Cancer Research Program: Breakthrough Fellowship Award
Application: 3/14/19
Breast Cancer Research Program: Era of Hope Scholar Award
Application: 3/14/19
Prostate Cancer Foundation
Young Investigator Awards in Prostate Cancer Research
Application: 3/18/19
PCF Challenge Awards For Metastatic, Lethal Prostate Cancer
Application: 4/22/19
Colorectal Cancer Alliance
Colorectal Cancer Prevention Grant
Application: 3/18/19